Bone marrow transplantation versus chemotherapy in non-Hodgkin's lymphoma Journal Article
| Authors: | Nimer, S. D.; Zelenetz, A.; Portlock, C. |
| Article Title: | Bone marrow transplantation versus chemotherapy in non-Hodgkin's lymphoma |
| Abstract: | To the Editor: In their study of the efficacy of high-dose chemotherapy and autologous bone marrow transplantation in patients with non-Hodgkin's lymphoma who respond slowly to chemotherapy, Verdonck et al. (April 20 issue)1 used response criteria that may have influenced the outcome. A variety of criteria have been proposed to assess response in patients with lymphoma, but the most widely accepted are those ratified at the Cotswolds meeting,2 which define a partial remission as “a decrease by at least 50 percent in the sum of the products of the largest perpendicular diameters of all measurable lesions.” In contrast, Verdonck et. © 1995, Massachusetts Medical Society. All rights reserved. |
| Keywords: | cancer survival; treatment outcome; prednisone; doxorubicin; cancer combination chemotherapy; dose response; drug efficacy; multimodality cancer therapy; note; combined modality therapy; antineoplastic agent; letter; classification; tumor volume; antineoplastic combined chemotherapy protocols; cyclophosphamide; vincristine; cancer regression; nonhodgkin lymphoma; statistical analysis; data interpretation, statistical; lymphoma, non-hodgkin; remission; remission induction; bone marrow transplantation; autologous bone marrow transplantation; human; priority journal |
| Journal Title: | New England Journal of Medicine |
| Volume: | 333 |
| Issue: | 11 |
| ISSN: | 0028-4793 |
| Publisher: | Massachusetts Medical Society |
| Date Published: | 1995-09-14 |
| Start Page: | 728 |
| End Page: | 729 |
| Language: | English |
| DOI: | 10.1056/nejm199509143331111 |
| PUBMED: | 7503899 |
| PROVIDER: | scopus |
| DOI/URL: | |
| Notes: | Letter -- Export Date: 28 August 2018 -- Source: Scopus |
Altmetric
Citation Impact
BMJ Impact Analytics
Related MSK Work